Loading...

China Oncology

30 July 2020, Volume 30 Issue 7
Cover and contents

2020 Issue 7 Cover

Abstract ( 327) PDF (2502KB) ( 696 )

Contents of Issue 7, 2020

Abstract ( 26) PDF (256KB) ( 390 )

Article

ARHGAP4 promotes growth of hepatocellular carcinoma cells by regulating HK2 expression

OUYANG Xiaochun , ZOU Yeqing , LI Yumei , DING Xiaobing

2020, 30 (7): 481-487. doi: 10.19401/j.cnki.1007-3639.2020.07.001

Abstract ( 638) PDF (3146KB) ( 2000 )

SAMHD1 inhibits the proliferation of hepatocellular carcinoma by regulating the expression of p27

PI Sidie, ZHENG Xiaochuan, MAO Binli, CUI Jing, HU Yuan

2020, 30 (7): 489-496. doi: 10.19401/j.cnki.1007-3639.2020.07.002

Abstract ( 697) PDF (2737KB) ( 1303 )

STC1 induces epithelial-mesenchymal transition to promote invasion and migration of lung cancer cells

WEI Lirong , TENG Xiaoyan , XIA Qianlin , DU Yuzhen

2020, 30 (7): 497-504. doi: 10.19401/j.cnki.1007-3639.2020.07.003

Abstract ( 853) PDF (2909KB) ( 1422 )

Radiogenomics: association between BI-RADS mammographic imaging features and the 21-gene recurrence score

CHEN Yang , LIU Wei , LI Ruimin , WANG Qifeng , SHEN Xigang , TANG Wei

2020, 30 (7): 505-511. doi: 10.19401/j.cnki.1007-3639.2020.07.004

Abstract ( 807) PDF (1552KB) ( 1382 )

Predictive value of immunocytochemical p16/Ki-67 double staining for cervical cytology negative and HR-HPV positive shunting and histological LSIL prognosis

QIU Xiaoyang , WANG Shaohong , ZHENG Jing , WU Xuan , WANG Yuanyuan , LIU Jun , YE Caiguo

2020, 30 (7): 512-518. doi: 10.19401/j.cnki.1007-3639.2020.07.005

Abstract ( 294) PDF (1231KB) ( 4860 )

Efficacy and prognostic factors of adjuvant radiotherapy combined with chemotherapy in patients with pancreatic cancer

ZHANG Xiaomeng , MA Ningyi , ZHU Hongcheng , AI Dashan , REN Zhigang

2020, 30 (7): 519-524. doi: 10.19401/j.cnki.1007-3639.2020.07.006

Abstract ( 350) PDF (1149KB) ( 1069 )

Association between Onodera’s prognostic nutrition index and adverse effects of concurrent chemoradiotherapy for esophageal squamous cell carcinoma

WU Jingwen, YU Xuejuan, YANG Qiu’an

2020, 30 (7): 525-530. doi: 10.19401/j.cnki.1007-3639.2020.07.007

Abstract ( 692) PDF (1091KB) ( 1675 )

Clinical characteristics and prognosis of long-term survivors of oral mucosal melanoma with recurrence and metastasis

LIANG Xiang , WU Yunteng

2020, 30 (7): 531-537. doi: 10.19401/j.cnki.1007-3639.2020.07.008

Abstract ( 329) PDF (1642KB) ( 1077 )

Review

Research progress of immunotherapy in ovarian cancer

ZHAO Haiyun, WU Xiaohua

2020, 30 (7): 538-545. doi: 10.19401/j.cnki.1007-3639.2020.07.009

Abstract ( 972) PDF (1093KB) ( 2531 )

The advantages and disadvantages of ultrasound risk stratification of thyroid nodules

MA Jiaojiao, ZHANG Bo

2020, 30 (7): 546-550.

Abstract ( 498) PDF (977KB) ( 1663 )

Guides and Consensus

Chinese expert consensus on genomic testing of prostate cancer patients (the 2020 edition)

China Anti-Cancer Association Genitourinary Cancer Committee, Chinese Society of Clinical Oncology Committee on Prostate Cancer

2020, 30 (7): 551-560. doi: 10.19401/j.cnki.1007-3639.2020.07.011

Abstract ( 1523) PDF (715KB) ( 4198 )

中国癌症杂志
    Database Indexing
  • A Guide to the Core Journals of China
  • Chinese Science Citation Database (CSCD)
  • China National Knowledge Infrastructure (CNKI)
  • Chinese Sci-tech Paper and Citation Database (CSTPCD)
  • Outsanding S&T Journals of China (2020) (F5000)
  • World Journal Clout Index (WJCI) Report of Scientific and Technological Periodicals (2021)
  • SCOPUS
  • EMBASE
  • DOAJ
  • Chemical Abstracts (CA)
  • Japan Science and Technology Database (JST)
  • The Western Pacific Region Index Medicus (WPRIM)
  • EBSCO
  • Index of Copernicus International (ICI)

Competent Authorities

 The Ministry of Education of the People’s Republic of China

Sponsored by

 Fudan University Shanghai Cancer Center

Edited by

 Editorial Board of China Oncology

Editor-in-Chief

 SHAO Zhimin

Honorary Editor-in-Chief

 TANG Zhaoyou, CAO Shilong, SHEN Zhenzhou

Printed by

 Shanghai Ouyang Printing Co., Ltd.

WeChat